These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1911932)

  • 1. Human gene therapy: ethics and public policy.
    Walters L
    Hum Gene Ther; 1991; 2(2):115-22. PubMed ID: 1911932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NIH "Points to Consider" and the limits of human gene therapy.
    Juengst ET
    Hum Gene Ther; 1990; 1(4):425-33. PubMed ID: 2078585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 5. Debates, divisions, and decisions: recombinant DNA advisory committee (RAC) authorization of the first human gene transfer experiments.
    Carmen IH
    Am J Hum Genet; 1992 Feb; 50(2):245-60. PubMed ID: 1734711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human gene therapy and congress.
    Cook-Deegan RM
    Hum Gene Ther; 1990; 1(2):163-70. PubMed ID: 2078577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human gene therapy: application, ethics and regulation.
    Baskerville G
    Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal regulation of human gene therapy.
    Areen J; King P
    Hum Gene Ther; 1990; 1(2):151-61. PubMed ID: 2078576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

  • 10. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1985 Dec; 8(4):176-80. PubMed ID: 3867980
    [No Abstract]   [Full Text] [Related]  

  • 12. Human gene therapy: a biopolitical overview and analysis.
    Carmen IH
    Hum Gene Ther; 1993 Apr; 4(2):187-93. PubMed ID: 8494928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The revised "Points to Consider" document.
    Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190
    [No Abstract]   [Full Text] [Related]  

  • 14. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 15. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of ethical debate about human gene therapy.
    Fletcher JC
    Hum Gene Ther; 1990; 1(1):55-68. PubMed ID: 2081187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy: regulatory issues and international approaches to regulation.
    Cohen-Haguenauer O
    Curr Opin Biotechnol; 1997 Jun; 8(3):361-9. PubMed ID: 9206021
    [No Abstract]   [Full Text] [Related]  

  • 19. Varmus's RAC attack worries Congress.
    Kaiser J
    Science; 1996 Jul; 273(5271):21. PubMed ID: 11644814
    [No Abstract]   [Full Text] [Related]  

  • 20. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.